Annexin A11 (ANXA11) (Middle Region) Peptide
ANXA11
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5671452
Aperçu rapide pour Annexin A11 (ANXA11) (Middle Region) Peptide (ABIN5671452)
Antigène
Annexin A11 (ANXA11)
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- GAGYPPVPPG GFGQPPSAQQ PVPPYGMYPP PGGNPPSRMP SYPPYPGAPV
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti- ANXA11 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Annexin A11 (ANXA11)
-
Sujet
-
This gene encodes a member of the annexin family, a group of calcium-dependent phospholipid-binding proteins. Annexins have unique N-terminal domains and conserved C-terminal domains, which contain calcium-dependent phospholipid-binding sites. The encoded protein is a 56-kD antigen recognized by sera from patients with various autoimmune diseases. Several transcript variants encoding two different isoforms have been identified.
Alias Symbols: ANX11, CAP50
Protein Size: 505 -
ID gène
- 311
-
NCBI Accession
- NM_001157, NP_001148
-
UniProt
- P50995
Antigène
-
Vous êtes ici:
